Skip to content

Opening book details…

About this Medicine article

Phase IB Study of the mTOR Inhibitor Ridaforolimus With Capecitabine by Perotti, A.; Locatelli, A.; Sessa, C.; Hess, D.; Vigano, L.; Capri, G.; Maur, M.; Cerny, T.; Cresta, S.; Rojo, F.; Albanell, J.; Marsoni, S.; Corradino, I.; Berk, L.; Rivera, V. M.; Haluska, F.; Gianni, L. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Perotti, A.; Locatelli, A.; Sessa, C.; Hess, D.; Vigano, L.; Capri, G.; Maur, M.; Cerny, T.; Cresta, S.; Rojo, F.; Albanell, J.; Marsoni, S.; Corradino, I.; Berk, L.; Rivera, V. M.; Haluska, F.; Gianni, L.
Publisher
American Society of Clinical Oncology; American Society of Clinical Oncology (ASCO) (ISSN 0732-183X)
Published
2010
Language
EN
Field
Medicine (Health Sciences)

More by Perotti, A.; Locatelli, A.; Sessa, C.; Hess, D.; Vigano, L.; Capri, G.; Maur, M.; Cerny, T.; Cresta, S.; Rojo, F.; Albanell, J.; Marsoni, S.; Corradino, I.; Berk, L.; Rivera, V. M.; Haluska, F.; Gianni, L.

Browse all works by Perotti, A.; Locatelli, A.; Sessa, C.; Hess, D.; Vigano, L.; Capri, G.; Maur, M.; Cerny, T.; Cresta, S.; Rojo, F.; Albanell, J.; Marsoni, S.; Corradino, I.; Berk, L.; Rivera, V. M.; Haluska, F.; Gianni, L.